Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2017 Earnings

9AugConfirmed

Q4 2016

Q1 2017

Q2 2017

Q3 2017

-4.27

-4.07

-3.86

-3.66

Details

Expected EPS

-3.6588139999999996

Actual EPS

-4.226561

Surprise EPS

-0.57

Surprise Percent

+15.52%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -4.226561 per share for Q3 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.